90Y-DOTA-TOC: Clinical Trials

1 trial of 90Y-DOTA-TOC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1

Follow 90Y-DOTA-TOC: new trials by email Literature Review of 90Y-DOTA-TOC trials Research Report on 90Y-DOTA-TOC

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor
90Y-DOTA-TOC, 68Ga-DOTA-TOC - Neuroendocrine Tumor
Early Phase 1CompletedThomas Hope102017-07-012020-07-07

Conditions studied

Neuroendocrine Tumors (1)

Sponsors

Thomas Hope (1)

Countries

United States (1)

Top investigators

Thomas Hope, MD (1)